other material
confidence high
sentiment neutral
materiality 0.50
SPAC Bellevue Life Sciences closes $60M IPO; $61.05M in trust, 9-month deadline for healthcare deal
OSR Holdings, Inc.
- IPO of 6,000,000 units at $10/unit raises $60M; each unit comprises one share, one warrant ($11.50 strike), and one right (1/10 share).
- Private placement of 430,000 units to sponsor Bellevue Global Life Sciences Investors LLC raises additional $4.3M.
- Total $61.05M deposited into trust account; funds not released until business combination, amendment vote, or liquidation within 9 months.
- Units trade on Nasdaq under BLACU; common stock, warrants, and rights to trade separately under BLAC, BLACW, and BLACR.
- Company intends to focus on healthcare industry targets for its initial business combination.